switching from dulaglutide to semaglutide Effects of liraglutide or in patients with type 2 diabetes: A randomized controlled trial - Iijima - 2023 - Journal of Diabetes Investigation Simulation scenarios for switching from

Stopping any of these medications abruptly can lead to rebound hunger, blood sugar fluctuations, and weight regain

Next up well tackle side effects which is in my opinion one of the rate limiters for my personal excitement for this drug class

The placebo-controlled SURMOUNT-OSA trial evaluated Zepbound for the treatment of moderate to severe OSA in adults with obesity, without type 2 diabetes mellitus (T2DM)

The supernatant was used to detect antioxidant biomarkers, such as the glutathione (GSH), total antioxidant capacity (T-AOC), content and malondialdehyde (MDA) levels, according to the manufacturers instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, China)